Monday, September 24, 2018

Challenge continues in developing effective drug treatment for Alzheimer's disease

Nilvadipine shows no benefit for the treatment of Alzheimer's disease in mild and moderate stages of the disease, but further studies targeting the early phase of the disease may be warranted.

from Top Health News -- ScienceDaily https://ift.tt/2zrNouF
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Hidden stem cells may be fueling spinal stenosis

Scientists have discovered a stem cell that appears to serve as a master source for tendon and ligament cells throughout the body. In lumbar...